Skip to Content

Riprazo

Active Substance: aliskiren
Common Name: aliskiren
ATC Code: C09XA02
Marketing Authorisation Holder: Novartis Europharm Ltd.
Active Substance: aliskiren
Status: Withdrawn
Authorisation Date: 2007-08-22
Therapeutic Area: Hypertension
Pharmacotherapeutic Group: Agents acting on the renin-angiotensin system

Therapeutic Indication

Treatment of essential hypertension.

The marketing authorisation for Riprazo has been withdrawn at the request of the marketing-authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide